article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Drugs.com

Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.The combination pill is the first and only FDA-approved triple combination.

article thumbnail

FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo

Drugs.com

FRIDAY, June 20, 2025 — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year. Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection. On Wednesday, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Prefilled Syringe Presentation for Shingles Vaccine

Drugs.com

Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). MONDAY, July 21, 2025 -- The U.S. The existing vaccine consists of two.

article thumbnail

FDA approves twice-yearly shot of Gilead drug for HIV prevention

BioPharma Drive: Drug Pricing

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.

article thumbnail

FDA Approves First Twice-a-Year HIV Prevention Shot

Drugs.com

FRIDAY, June 20, 2025 — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year.On Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection that was shown to. Wednesday, the U.S.

article thumbnail

FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo

Drugs.com

Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE). THURSDAY, July 24, 2025 — The U.S. CHE is common condition marked by redness, itching and cracking on the.

article thumbnail

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

Drugs.com

Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent attacks of hereditary angioedema (HAE). FRIDAY, June 20, 2025 -- The U.S. According to the Mayo.